SARSTEDT to become majority shareholder of Timedico
8 Apr 2020SARSTEDT AG & Co. KG, a world leading supplier of consumables and instruments for medicine and science, and Timedico A/S, a company that develops and markets a one-touch blood sample transportation system, have announced that SARSTEDT AG & Co. KG has acquired 80% of the shares in Timedico and secured a right to acquire additional 20% in the near future. Daniel Blak one of the selling shareholders will continue to lead the operations as CEO of Timedico from the date of closing.
“We are delighted of the unique addition to SARSTEDT, providing our healthcare customers with a more diversified pre-analytical solution portfolio” states Jürgen Sarstedt, share-holder and chairman of SARSTEDT’s supervisory board. “By combining Timedico’s Tempus600® blood sample transportation system with our unique S-Monovette® blood collection system and our lab automation solutions we leverage our value proposition to our global customers.”
Timedico is a growing company providing its medical transport solution to healthcare providers across 21 countries. Their Tempus600® lineup enables the one-touch sample transport from the point of collection to the laboratory.
“I look forward to the incredibly exciting future, in which we, with the support of SARSTEDT, will be enabled to significantly expand the reach of our solution, bringing the potential of Tempus600® to fruition, to the benefit of our customers as well as our employees.”, said Daniel Blak.
Rainer Schuster, Member of the Executive Board Sales / Research & Development, concludes, “We are welcoming the Timedico employees to SARSTEDT. With their product portfolio they are a perfect addition to us, and we are excited for a seamless and unique product portfolio for the entire pre-analytical work flow. We have been working on this transaction for many months and we are glad that we managed to conclude the deal.”
Want more of the latest science news straight to your inbox? Become a SelectScience member for free today>>